Clinical Trials List
2014-08-08 - 2018-12-31
Phase I
Terminated4
ICD-10C78.00
Secondary malignant neoplasm of unspecified lung
ICD-10C78.01
Secondary malignant neoplasm of right lung
ICD-10C78.02
Secondary malignant neoplasm of left lung
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9197.0
Secondary malignant neoplasm of lung
-
Trial Applicant
Boehringer Ingelheim
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- James Chih-Hsin Yang Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Wen-Pin Su Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 林孟志 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 林裕清 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 (part A) participants
-
Global
24 (part A) participants
